Mayfair Pharmacare Limited

POWER SEARCH PRICING

SOLUTIONS

mayfair pharmacare limited Company Information

Company Number

07147533

Next Accounts

76 days late

Directors

Neal Radia

Shareholders

radiant medicare limited

neal radia

Group Structure

View All

Industry

Dispensing chemist in specialised stores

Registered Address

2 burton house repton place, white lion road, amersham, buckinghamshire, HP7 9LP

Website

mayfair pharmacare limited Estimated Valuation

£1.1m

Pomanda estimates the enterprise value of MAYFAIR PHARMACARE LIMITED at £1.1m based on an EBITDA of £250.7k and a 4.29x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Mayfair Pharmacare Limited is a live company located in amersham, HP7 9LP with a Companies House number of 07147533. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in February 2010, it's largest shareholder is radiant medicare limited with a 75% stake. Mayfair Pharmacare Limited is a established, small sized company, Pomanda has estimated its turnover at £946.1k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Mayfair Pharmacare Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

2 Strong

2 Regular

7 Weak

Size

annual sales of £946.1k, make it smaller than the average company (£12.8m)

Growth

3 year (CAGR) sales growth of -21%, show it is growing at a slower rate (4.5%)

EXPORT

Mayfair Pharmacare Limited's latest turnover from April 2023 is £946.1 thousand and the company has net assets of £377.1 thousand. According to their latest financial statements, Mayfair Pharmacare Limited has 6 employees and maintains cash reserves of £1.1 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012
Turnover	946,142	1,785,292	993,301	1,946,789	5,769,427	5,786,996	4,958,029	5,122,899	9,479,913	9,136,930	7,817,630	5,804,794
Other Income Or Grants
Cost Of Sales	601,567	1,106,691	626,404	1,206,984	3,601,077	3,608,646	3,019,036	3,200,149	6,020,182	5,899,054	5,168,643	3,671,922
Gross Profit	344,575	678,601	366,898	739,805	2,168,350	2,178,350	1,938,993	1,922,749	3,459,731	3,237,876	2,648,987	2,132,871
Admin Expenses	173,461	577,873	3,362,930	-2,247,111	1,384,414	2,035,028	1,945,087	1,373,375	3,258,386	3,305,862	2,622,126	2,223,021
Operating Profit	171,114	100,728	-2,996,032	2,986,916	783,936	143,322	-6,094	549,374	201,345	-67,986	26,861	-90,150
Interest Payable				2,105	37,799	71,013	79,110	74,446	66,549	81,316	91,641	47,846
Interest Receivable	2,105	1,520	2,002	1,913	448	876	1,375	2,077	223	34
Pre-Tax Profit	173,219	102,248	-2,994,030	2,986,723	746,585	73,185	-83,829	477,005	135,019	-149,268	-64,780	-137,996
Tax	-22,152	-19,427		-567,477	-141,851	-13,905		-95,401	-27,004
Profit After Tax	151,067	82,821	-2,994,030	2,419,246	604,734	59,280	-83,829	381,604	108,015	-149,268	-64,780	-137,996
Dividends Paid
Retained Profit	151,067	82,821	-2,994,030	2,419,246	604,734	59,280	-83,829	381,604	108,015	-149,268	-64,780	-137,996
Employee Costs	231,352	292,480	254,371	945,048	1,410,092	1,362,326	1,246,193	1,077,644	1,607,047	1,796,834	1,595,901	1,161,849
Number Of Employees	6	8	7	26	40	41	40	36	63	65	55	43
EBITDA*	250,689	106,722	-2,995,914	2,986,916	1,032,420	446,670	321,251	919,371	538,581	267,533	314,058	114,285

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012
Tangible Assets	44,392	47,067	3,432		119,293	76,535	103,466	163,432	235,014	332,669	671,842	325,342
Intangible Assets		1,309,864	335,624		390,000	955,500	1,210,500	1,465,500	1,480,500	1,711,500	1,732,500	1,942,500
Investments & Other				245,406	245,406	245,406	245,406	245,406	245,406	245,406
Debtors (Due After 1 year)	10,500	10,500	10,500		39,364	39,364	43,275	43,275	43,275	43,275	43,275
Total Fixed Assets	54,892	1,367,431	349,556	245,406	794,063	1,316,805	1,602,647	1,917,613	2,004,195	2,332,850	2,447,617	2,267,842
Stock & work in progress		92,736	50,882		280,037	397,969	405,784	401,484	422,285	421,828	420,983	347,586
Trade Debtors	110,614	366,929	138,606	13,050	881,994	1,007,348	659,311	767,962	1,210,548	1,077,597	923,368	819,094
Group Debtors	93,100	14,000	349,618	16,096		6,667	17,227
Misc Debtors	9,601	83,273	22,138	36,712	120,492	138,495	142,125	155,732
Cash	1,067,954	111,884	293,529	3,711,381	113,704	5,781	344,790	755,237	75,685	13,519
misc current assets
total current assets	1,281,269	668,822	854,773	3,777,239	1,396,227	1,556,260	1,569,237	2,080,415	1,708,518	1,512,944	1,344,351	1,166,680
total assets	1,336,161	2,036,253	1,204,329	4,022,645	2,190,290	2,873,065	3,171,884	3,998,028	3,712,713	3,845,794	3,791,968	3,434,522
Bank overdraft					17,424	428,922	258,167	254,519
Bank loan
Trade Creditors	26,914	216,468	115,152	52,188	594,459	438,340	612,508	901,136	2,054,888	2,026,983	1,767,166	1,305,622
Group/Directors Accounts	641,705	1,196,409				402,052	401,160	400,005
other short term finances
hp & lease commitments
other current liabilities	290,478	397,379	946,001	643,686	552,887	482,665	451,290	479,147
total current liabilities	959,097	1,810,256	1,061,153	695,874	1,164,770	1,751,979	1,723,125	2,034,807	2,054,888	2,026,983	1,767,166	1,305,622
loans					51,593	622,035	875,888	1,142,958	893,170	1,154,487	1,347,546	1,472,175
hp & lease commitments
Accruals and Deferred Income
other liabilities				189,565	246,198	385,825	518,423	674,423	1,008,484	1,016,168	879,832	794,521
provisions					9,769		502	8,065
total long term liabilities				189,565	307,560	1,007,860	1,394,813	1,825,446	1,901,654	2,170,655	2,227,378	2,266,696
total liabilities	959,097	1,810,256	1,061,153	885,439	1,472,330	2,759,839	3,117,938	3,860,253	3,956,542	4,197,638	3,994,544	3,572,318
net assets	377,064	225,997	143,176	3,137,206	717,960	113,226	53,946	137,775	-243,829	-351,844	-202,576	-137,796
total shareholders funds	377,064	225,997	143,176	3,137,206	717,960	113,226	53,946	137,775	-243,829	-351,844	-202,576	-137,796

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012
Operating Activities
Operating Profit	171,114	100,728	-2,996,032	2,986,916	783,936	143,322	-6,094	549,374	201,345	-67,986	26,861	-90,150
Depreciation	12,626	5,994	118		20,984	48,348	72,345	114,997	106,236	104,519	77,197	46,935
Amortisation	66,949				227,500	255,000	255,000	255,000	231,000	231,000	210,000	157,500
Tax	-22,152	-19,427		-567,477	-141,851	-13,905		-95,401	-27,004
Stock	-92,736	41,854	50,882	-280,037	-117,932	-7,815	4,300	-20,801	457	845	73,397	347,586
Debtors	-250,887	-46,160	455,004	-975,992	-150,024	329,936	-105,031	-286,854	132,951	154,229	147,549	819,094
Creditors	-189,554	101,316	62,964	-542,271	156,119	-174,168	-288,628	-1,153,752	27,905	259,817	461,544	1,305,622
Accruals and Deferred Income	-106,901	-548,622	302,315	90,799	70,222	31,375	-27,857	479,147
Deferred Taxes & Provisions				-9,769	9,769	-502	-7,563	8,065
Cash flow from operations	275,705	-355,705	-3,136,521	3,214,227	1,394,635	-32,651	97,934	465,085	406,074	372,276	554,656	253,227
Investing Activities
capital expenditure	1,232,964	-1,023,869	-339,174	509,293	274,258	-21,417	-12,379	-283,415	-8,581	24,654	-423,697	-2,472,277
Change in Investments			-245,406							245,406
cash flow from investments	1,232,964	-1,023,869	-93,768	509,293	274,258	-21,417	-12,379	-283,415	-8,581	-220,752	-423,697	-2,472,277
Financing Activities
Bank loans
Group/Directors Accounts	-554,704	1,196,409			-402,052	892	1,155	400,005
Other Short Term Loans
Long term loans				-51,593	-570,442	-253,853	-267,070	249,788	-261,317	-193,059	-124,629	1,472,175
Hire Purchase and Lease Commitments
other long term liabilities			-189,565	-56,633	-139,627	-132,598	-156,000	-334,061	-7,684	136,336	85,311	794,521
share issue												200
interest	2,105	1,520	2,002	-192	-37,351	-70,137	-77,735	-72,369	-66,326	-81,282	-91,641	-47,846
cash flow from financing	-552,599	1,197,929	-187,563	-108,418	-1,149,472	-455,696	-499,650	243,363	-335,327	-138,005	-130,959	2,219,050
cash and cash equivalents
cash	956,070	-181,645	-3,417,852	3,597,677	107,923	-339,009	-410,447	679,552	62,166	13,519
overdraft				-17,424	-411,498	170,755	3,648	254,519
change in cash	956,070	-181,645	-3,417,852	3,615,101	519,421	-509,764	-414,095	425,033	62,166	13,519

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for mayfair pharmacare limited. Get real-time insights into mayfair pharmacare limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for mayfair pharmacare limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HP7 area or any other competitors across 12 key performance metrics.

MAYFAIR PHARMACARE LIMITED group structure

Mayfair Pharmacare Limited has no subsidiary companies.

Ultimate parent company

RADIANT MEDICARE LIMITED

06555203

1 parent

MAYFAIR PHARMACARE LIMITED

07147533

MAYFAIR PHARMACARE LIMITED Shareholders

radiant medicare limited	75%
neal radia	25%

Mayfair Pharmacare Limited currently has 1 director, Mr Neal Radia serving since Feb 2011.

officer	country	age	start	end	role
Mr Neal Radia	England	41 years	Feb 2011	-	Director

P&L

April 2023

turnover

946.1k

operating profit

171.1k

gross margin

36.5%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

377.1k

+0.67%

total assets

1.3m

-0.34%

cash

1.1m

+8.55%

net assets

Total assets minus all liabilities

Similar Companies

green cross chemists limited

gleoresa limited

dipchem limited

care pharmacy limited

simray limited

company number

07147533

Type

Private limited with Share Capital

industry

47750 - Retail sale of cosmetic and toilet articles in specialised stores

47730 - Dispensing chemist in specialised stores

47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores

incorporation date

February 2010

ultimate parent company

RADIANT MEDICARE LIMITED

previous names

N/A

address

2 burton house repton place, white lion road, amersham, buckinghamshire, HP7 9LP

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 11 charges/mortgages relating to mayfair pharmacare limited. Currently there are 0 open charges and 11 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MAYFAIR PHARMACARE LIMITED. This can take several minutes, an email will notify you when this has completed.

mayfair pharmacare limited Company Information

mayfair pharmacare limited Estimated Valuation

mayfair pharmacare limited Estimated Valuation

mayfair pharmacare limited Estimated Valuation

Mayfair Pharmacare Limited Overview

Mayfair Pharmacare Limited Health Check

MAYFAIR PHARMACARE LIMITED financials

mayfair pharmacare limited Credit Report and Business Information

Mayfair Pharmacare Limited Competitor Analysis

mayfair pharmacare limited Ownership

mayfair pharmacare limited directors

mayfair pharmacare limited company details

mayfair pharmacare limited Charges & Mortgages

mayfair pharmacare limited Capital Raised & Share Issues BETA

mayfair pharmacare limited Companies House Filings - See Documents